Cardiovascular screening and the elite athlete: advances, concepts, controversies, and a view of the future

Robert W Battle; Dilaawar J Mistry; Rohit Malhotra; John M Macknight; Ethan N Saliba; Srijoy Mahapatra

doi:10.1016/j.csm.2011.03.001

Cardiovascular screening and the elite athlete: advances, concepts, controversies, and a view of the future

Clin Sports Med. 2011 Jul;30(3):503-24. doi: 10.1016/j.csm.2011.03.001.

Authors

Robert W Battle¹, Dilaawar J Mistry, Rohit Malhotra, John M Macknight, Ethan N Saliba, Srijoy Mahapatra

Affiliation

¹ Department of Medicine, Adult Congenital Heart Clinic, University of Virginia Health System, Charlottesville, VA 22908-0158, USA. RWB2FB@hscmail.mcc.virginia.edu

PMID: 21658545
DOI: 10.1016/j.csm.2011.03.001

Abstract

This article addresses programmatic cardiovascular screening and evaluation of the elite athlete at the intercollegiate, national team, professional, and Olympic levels. Although much of this content may apply to high-school and recreational sports at large, it is not specifically designed to address athletes participating in all sports activities.

MeSH terms

Athletes*
Cardiomyopathy, Hypertrophic / diagnosis*
Cardiomyopathy, Hypertrophic / genetics
Death, Sudden, Cardiac / prevention & control
Electrocardiography
Humans
Mass Screening / trends*